Abstract: The present invention relates to a pharmaceutical composition for preventing or treating inflammatory bowel disease, comprising extracts of Isatidis folium and Juglans mandshurica. In addition, the present invention relates to a food composition or an animal feed composition for preventing or alleviating inflammatory bowel disease, both comprising the extracts.

Abstract: The present invention relates to a novel Lactobacillus paracasei NK112 strain that has the effect of preventing or treating cognitive dysfunction and intestinal dysfunction. In addition, the present invention relates to a composition for prevention, treatment, or alleviation of cognitive dysfunction and intestinal dysfunction, comprising a Lactobacillus paracasei NK112 strain, a Cuscuta australis R.Br. extract, and a Cuscuta japonica Choisy extract. The strain and the composition, of the present invention, exhibit efficacy in increasing the expression of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), alleviating intestinal inflammation, and the like, and thus can be effectively used in the prevention or treatment of cognitive dysfunction and intestinal dysfunction.

Abstract: The present invention relates to a composition for the diagnosis of a degenerative brain disease, comprising hpmA, which is a substance derived from Proteus, Shigella, Klebsiella pneumoniae, or Citrobacter, preferably a Proteus mirabilis strain, from a biological sample of a subject. In addition, the present invention relates to a method for providing information for the diagnosis of a degenerative brain disease such as Parkinson's disease, brain neuritis (neuroinflammation), or Alzheimer's disease, by measuring the amount of hpmA.

Abstract: The present invention relates to a composition for improving insulin sensitivity, comprising a Gentiana trillora Pallas extract. The composition according to the present invention improves insulin sensitivity by reducing the expression of ITIH1, and thus can be effectively used as a therapeutic agent for diabetes, diabetic complications, impaired glucose tolerance, insulin resistance syndrome and the like.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating inflammatory bowel disease, comprising an Isatidis folium extract. In addition, the present invention relates to a food composition or animal feed composition for preventing or improving inflammatory bowel disease, comprising the Isatidis folium extract.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating neurodegenerative diseases, the composition containing a mixed herbal extract of Genkwae Flos, Clematidis Radix, and Gastrodiae Rhizoma. In addition the present invention relates to a food composition or feedstuff composition for preventing or improving neurodegenerative diseases, wherein the composition contains the herbal extract.

Abstract: The present invention relates to a composition for preventing and/or treating a stroke or a degenerative brain disease comprising: at least two substances selected from the group consisting of egg yolk lecithin, glycerol, sodium oleate, medium chain triglyceride and refined fish oil; olive oil; and soybean oil. The composition of the present invention has an excellent neuroprotective effect but no toxicity or side effects, and thus can be effectively and safely used for preventing, treating or ameliorating a stroke or a degenerative brain disease.

Abstract: A composition, a health functional food or a treatment method of the present invention has a remarkable cranial nerve cell protection effect and simultaneously has a sensorimotor function recovery promotion effect and a body weight increasing effect. Accordingly, the present invention has effects of preventing stroke or neurodegenerative diseases, protecting cranial nerve cell cells over the mid to long term immediately after the onset of disease, promoting the recovery of a sensorimotor function reduced by stroke and neurodegenerative diseases, and increasing a reduced body weight. Therefore, the present invention can be used for effectively preventing, treating or managing stroke and neurodegenerative diseases.

Abstract: An electronic device according to various embodiments of the present invention may comprise: a body portion comprising a first surface facing in a first direction, a second surface facing in a second direction that is opposite to the first direction, and a seating groove arranged in an inner peripheral area thereof in the longitudinal direction; a display portion rotatably coupled to the body portion; and a connector module arranged in the seating groove of the body portion so as to provide electric coupling between the body portion and the display portion, at least a part of the connector module being configured to rotate.

Abstract: An electronic device according to various embodiments of the present invention may comprise: a body portion comprising a first surface facing in a first direction, a second surface facing in a second direction that is opposite to the first direction, and a seating groove arranged in an inner peripheral area thereof in the longitudinal direction; a display portion rotatably coupled to the body portion; and a connector module arranged in the seating groove of the body portion so as to provide electric coupling between the body portion and the display portion, at least a part of the connector module being configured to rotate.

Abstract: Provided is an information providing method for diagnosing Parkinson's disease by measuring the amount of any one target selected from the group consisting of a Proteus mirabilis strain, a metabolite produced by the Proteus mirabilis strain, and ?-synuclein in a biological sample of a subject; a composition comprising a Proteus mirabilis strain as an active ingredient for fabricating a Parkinson's disease animal model; a method for fabricating a Parkinson's disease animal model, the method comprising a step for administering a Proteus mirabilis strain to an animal excluding human; and a method for screening a Parkinson's disease medicine, the method comprising a step for administering a candidate drug of the Parkinson's disease medicine to the Parkinson's disease animal model and a step for observing the degree of mitigation of Parkinson's disease symptoms to determine the treatment effect of the candidate drug on Parkinson's disease.

Abstract: The present invention provides a pharmaceutical composition containing a Sceptridium japonicum extract, as an active ingredient, for preventing or treating stroke or degenerative brain diseases. The Sceptridium japonicum extract of the present invention has a protective effect on cranial nerves so as to exhibit a functional effect of preventing or treating stroke or various degenerative brain diseases.

Abstract: The present invention relates to a composition for preventing and/or treating a stroke or a degenerative brain disease comprising: at least two substances selected from the group consisting of egg yolk lecithin, glycerol, sodium oleate, medium chain triglyceride and refined fish oil; olive oil; and soybean oil. The composition of the present invention has an excellent neuroprotective effect but no toxicity or side effects, and thus can be effectively and safely used for preventing, treating or ameliorating a stroke or a degenerative brain disease.

Abstract: A composition, a health functional food or a treatment method of the present invention has a remarkable cranial nerve cell protection effect and simultaneously has a sensorimotor function recovery promotion effect and a body weight increasing effect. Accordingly, the present invention has effects of preventing stroke or neurodegenerative diseases, protecting cranial nerve cell cells over the mid to long term immediately after the onset of disease, promoting the recovery of a sensorimotor function reduced by stroke and neurodegenerative diseases, and increasing a reduced body weight. Therefore, the present invention can be used for effectively preventing, treating or managing stroke and neurodegenerative diseases.

Abstract: A docking station for an electronic device includes a station body to which the electronic device is detachably docked, at least one locking unit comprising a hook member to move between a first position in which the station body and the electronic device are connected and a second position in which the station body is separated from the electronic device, and a lock maintaining unit to maintain the hook member in the first position.

Abstract: The present invention relates to a composition for preventing and/or treating a stroke or a degenerative brain disease comprising: at least two substances selected from the group consisting of egg yolk lecithin, glycerol, sodium oleate, medium chain triglyceride and refined fish oil; olive oil; and soybean oil. The composition of the present invention has an excellent neuroprotective effect but no toxicity or side effects, and thus can be effectively and safely used for preventing, treating or ameliorating a stroke or a degenerative brain disease.

Abstract: The present invention provides a pharmaceutical composition containing a Sceptridium japonicum extract, as an active ingredient, for preventing or treating stroke or degenerative brain diseases. The Sceptridium japonicum extract of the present invention has a protective effect on cranial nerves so as to exhibit a functional effect of preventing or treating stroke or various degenerative brain diseases.

Abstract: A docking station for an electronic device includes a station body to which the electronic device is detachably docked, at least one locking unit comprising a hook member to move between a first position in which the station body and the electronic device are connected and a second position in which the station body is separated from the electronic device, and a lock maintaining unit to maintain the hook member in the first position.

Abstract: A method of and an apparatus for displaying temperature on a radio telephone. The temperature apparatus includes a key pad for producing a temperature mode or a speech mode, a device for measuring current room or environment temperature, analog/digital converting device for converting current room or environment temperature into a digital value, and a microcomputer for storing the digital temperature value in a memory of the radio telephone. The method includes the steps of a) using key for determining whether a temperature mode is selected, b) reading current environment temperature through the temperature measuring device, and displaying the measured current temperature on a liquid crystal display for a predetermined time, c) stopping the temperature mode, and converting the temperature mode into a speech mode.